Tuberculosis Transmission Risk and Contact‑Investigation Guidelines

1. Mechanism of Transmission

Airborne droplet nuclei are the primary vehicle for Mycobacterium tuberculosis spread; infection risk rises markedly after roughly 250 cumulative exposure hours, although transmission can occur with much shorter contact in certain settings 1.

Pulmonary or laryngeal TB with a positive sputum AFB smear is the most contagious presentation 1, 2, 3.
Cavitary disease on chest radiograph confers higher infectiousness due to larger organism burden and more frequent coughing 1, 3.
Frequent, forceful coughing amplifies aerosol generation and transmission risk 1, 2.
High sputum bacillary load (≈10⁶–10⁸ organisms /ml at diagnosis) is associated with greater transmission potential 4.
AFB smear‑negative patients still contribute to transmission, accounting for about 17 % of TB spread 1, 2.

Limited air volume and poor ventilation concentrate infectious particles, markedly raising transmission risk 5, 1.
Confined spaces (e.g., small rooms, poorly ventilated areas) dramatically increase risk regardless of exposure duration 5, 3.
Closer physical proximity to the source case elevates the likelihood of infection 5, 1.

Approximately 30–40 % of close personal contacts show evidence of infection by the time the source case is diagnosed 1, 2.
A practical threshold for significant exposure is ≥120 hours per month; contacts exceeding this duration merit full investigation [5].
For airline passengers, seating in the same or adjoining row for >8 hours with an infectious case significantly raises infection risk 5.

HIV infection markedly increases both the risk of acquiring infection and progression to active disease 5, 6.
Children younger than 5 years have a higher propensity for rapid progression after infection 5, 6.
Immunosuppression (e.g., prednisone > 15 mg/day for > 4 weeks, TNF‑α antagonists) heightens susceptibility 5, 7.

The interval from exposure to a detectable tuberculin skin‑test reaction is 8–10 weeks; testing before 8 weeks may miss infection and should be repeated at the end of this window 6.

After 2 days of effective multidrug therapy, viable bacilli in sputum are reduced by ≈90 % 4.
Between 14–21 days of therapy, viable organisms decline by >99 % 4.
A general benchmark for markedly reduced infectiousness is 2–3 weeks of standard therapy combined with clinical improvement 4.
For multidrug‑resistant TB, three consecutive negative AFB sputum smears are required before the patient is considered non‑infectious 4.

The CDC/NTCA guidelines state that no safe exposure threshold exists for airborne Mycobacterium tuberculosis; even a single bacterium could theoretically cause infection, so transmission can occur after exposures as brief as 5 minutes 8.

Small, poorly ventilated spaces markedly increase the risk of transmission regardless of exposure duration; confined environments concentrate infectious droplet nuclei and make brief contacts far more hazardous 8.
Proximity to the source case is a critical determinant—the closer a person is to an infectious individual, the higher the likelihood of acquiring infection 8.

Children younger than 5 years (especially those under 3 years) should receive a full TB evaluation after any exposure, irrespective of duration 9.
People living with HIV must be fully evaluated after any exposure, regardless of how brief the contact was 10.
Individuals with other conditions that predispose to progression of TB infection (e.g., immunosuppressive therapy) also require full evaluation 9.

All contacts should undergo tuberculin skin testing (TST) unless they have documented prior positive results 10.
The optimal window for detecting infection is 8–10 weeks after the end of exposure; testing earlier may miss infection and should be repeated at the end of this window 10.
An induration of ≥5 mm on TST is considered positive for any TB contact 10.

Contact investigations are justified when exposure occurs in unusually confined, poorly ventilated spaces 8.
Investigations are also warranted if the source patient has highly infectious disease (e.g., smear‑positive, cavitary pulmonary TB) 8.
When vulnerable populations such as young children or immunocompromised persons are exposed, a brief exposure still warrants investigation 8.

High‑risk contacts (e.g., children <5 years, immunocompromised individuals) should receive window prophylaxis and repeat testing even if the initial TST is negative 11.